Study may lead to new treatments for prostate cancer
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
Cancer
Mar 21, 2012 |
not rated yet |
0
Evidence mounts for link between opioids and cancer growth
Opioid drugs used to relieve pain in postoperative and chronic cancer patients may stimulate the growth and spread of tumors, according to two studies and a commentary in the 2012 annual Journal Symposium issue of Anesthesiology, the ac ...
Cancer
Mar 20, 2012 |
4.6 / 5 (5) |
1
|
The USP15 biological thermostat: A promising novel therapeutic target in cancer
After years studying the molecular bases of glioblastoma - the most common brain tumor and one of the most aggressive of all cancers, the group led by Dr. Joan Seoane , Director of Translational Research at the Vall d'Hebron ...
Cancer
Feb 19, 2012 |
5 / 5 (1) |
0
|
Study explains high platelets in ovarian cancer patients, survival reduced
Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in ...
Cancer
Feb 15, 2012 |
not rated yet |
0
Drugs targeting chromosomal instability may fight a particular breast cancer subtype
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson's Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD., FACP, Director of the KCC and Chair of the Department of ...
Cancer
Feb 06, 2012 |
5 / 5 (1) |
0
|
New method to manage stress responses for more successful tumor removal
The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body's immune responses, ...
Cancer
Jan 30, 2012 |
not rated yet |
0
FDA clears Pfizer drug for advanced kidney cancer
(AP) -- The Food and Drug Administration has approved a new Pfizer drug for patients with advanced kidney cancer that has spread to other parts of the body despite treatment with at least one previous drug.
Medications
Jan 27, 2012 |
5 / 5 (2) |
0
Danish health care fast track program reduces cancer patients' treatment, diagnosis wait time
In Denmark, implementing a national fast track system for cancer patients reduced the waiting time between a patient's initial meeting with a health care provider and their first treatment by four weeks when comparing 2010 ...
Cancer
Jan 26, 2012 |
not rated yet |
0
Metastasis of pancreatic cancer in action
Ben Stanger, MD, PhD, assistant professor of Medicine in the Division of Gastroenterology at the Perelman School of Medicine, University of Pennsylvania, and Andrew Rhim, MD, a Gastroenterology Fellow in the ...
Cancer
Jan 19, 2012 |
5 / 5 (1) |
0
|
Radiation-induced damage to brain tissue reversed by oxygen starvation in mice
Treating brain tumors with whole brain radiation therapy can damage healthy brain tissue, but a new study in mice reveals that limiting the oxygen supply, or hypoxia, can alleviate some of the cognitive impairment caused ...
Other
Jan 18, 2012 |
not rated yet |
0
Study finds that tumor cells can prevent cancer spread
A new study finds that a group of little-explored cells in the tumor microenvironment likely serve as important gatekeepers against cancer progression and metastasis. Published in the January 17 issue of Cancer Cell, these ...
Cancer
Jan 17, 2012 |
5 / 5 (1) |
0
|
Fibroblasts contribute to melanoma tumor growth: study
Fibroblasts, cells that play a role in the structural framework of tissues, play an apparent role in melanoma tumor growth. Fibroblasts also contribute to melanoma drug resistance and may also facilitate the "flare" response ...
Cancer
Jan 05, 2012 |
not rated yet |
0
|
RTOG activates study to determine best treatment strategies for patients with glioma brain tumors
Treatment remains controversial for patients diagnosed with a low-risk, low-grade glioma (LGG) brain tumor. These patients have significantly better prognosis than patients diagnosed with more aggressive high-grade glioma, ...
Cancer
Dec 15, 2011 |
not rated yet |
0
Everolimus prolongs progression-free survival for patients with neuroendocrine tumors
Combination treatment with everolimus, an inhibitor of the mammalian target rapamycin (mTOR), and octreotide has shown to improve progression-free survival for patients with advanced neuroendocrine tumors and a history of ...
Cancer
Nov 29, 2011 |
not rated yet |
0
|
New target identified to stop the spread of breast cancer
A new potential target to slow breast cancer tumor progression and metastasis has been identified by a team of researchers led by Dr. Richard Kremer from the Research Institute of the McGill University Health Centre (RI-MUHC). ...
Cancer
Nov 10, 2011 |
5 / 5 (1) |
0
